By Rukhsar Bano
WHO Chief Scientist Soumya Swaminathan gave this information on Sunday. He told that the meeting of the Technical Advisory Group is to be held on October 26, in which the approval for emergency use of Covaxin will be considered.
The Indian corona vaccine Covaxin may get approval for emergency use from the World Health Organization (WHO) by the end of October. The meeting of the technical group of WHO is to be held on 26 October. In this, Hyderabad-based Biotech’s corona vaccine “Covaccine” will be considered for emergency use.
WHO Chief Scientist Soumya Swaminathan gave this information on Sunday. He said that the technical advisory group is to meet on October 26, in which it will be considered to approve the emergency use of Covaxin. He said, India is working closely with Biotech to complete the WHO dossier.
Bharat Biotech is continuously providing data
Soumya Swaminathan said, “We aim to expand the reach of a broad portfolio of vaccines approved for emergency use and reach populations everywhere. Earlier this month, the WHO tweeted saying, Covaccine is providing data on an ongoing basis. Additional information given on 27 September, WHO specials are currently reviewing this information to see if all standards are met
Covaccine has been developed by Bharat Biotech in collaboration with the India Council of Medical Research (ICMR) and the National Institute of Virology (NIV), Pune. Covaccine is an inactivated vaccine made by inactivating the virus that causes disease. Bharat Biotech filed an expression of interest for its vaccine on 19 April. The WHO said it began rolling out vaccine data on 6 July.